Jaume Pons - 25 Jul 2023 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role: President & CEO, Director
Signature: /s/ Peter Garcia, by power of attorney
Issuer symbol: ALXO
Transactions as of: 25 Jul 2023
Transactions value $: $0
Form type: 4
Date filed: 27 Jul 2023, 16:11
Previous filing: 05 Jul 2023
Next filing: 03 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALXO	Common Stock	Award	$0	+89K	+16.59%	$0.00	626K	25 Jul 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALXO	Employee Stock Option (right to buy)	Award	$0	+282K		$0.00	282K	25 Jul 2023	Common Stock	282K	$5.86	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023.
F2	Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023.